Karl Deisseroth, Peter Hegemann, and Georg Nagel Win Nobel Prize for Optogenetics

Karl Deisseroth, Peter Hegemann, and Georg Nagel won the 2026 Nobel Prize in Physiology or Medicine for discovering and developing optogenetics, a method that uses light-sensitive proteins to control nerve cells in living tissue. The German-American trio will share the 12 million kronor prize for laying foundational tools that let neuroscientists track how neural circuits form memories, emotions, and behaviors. While some focused on the debate over credit among junior researchers and senior lab heads, others highlighted the personal celebrations inside Stanford University when Deisseroth shared the news with his children.

How Light-Sensitive Proteins From Algae Form a Molecular Switch for Neurons

The breakthrough started in the early 1990s when Peter Hegemann began studying the single-celled alga Chlamydomonas and its unique sensitivity to light. Hegemann and Georg Nagel successfully used the algal light-sensitive protein channelrhodopsin to make non-neuronal cells responsive to light by inserting the gene into embryonic hamster kidney cells and generating an electrical signal. Karl Deisseroth later took that discovery into neuroscience at Stanford University, turning the protein into a targeted, light-operated switch for nerve cells and proving it functioned in the brains of living mice. Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine, noted in a press statement that optogenetics gives researchers capabilities for mapping the brain that were previously unimaginable.

Why The Nobel Committee Faces Growing Criticism Over Junior Researcher Credit

Histories of the award will record only Deisseroth’s name alongside Hegemann and Nagel, sparking pointed discussions across academic circles on X. Critics argue that senior lab directors receive the prestige for experiments executed by junior personnel, noting that the research report introducing channelrhodopsin in mammalian cells was fronted by then-graduate student Edward Boyden from Deisseroth’s laboratory. Thomas Perlmann, secretary in the medicine prize committee, told reporters that the committee investigates contributions rigorously with international experts and detailed publication reviews.

What Limits on Three Prize Recipients Mean for Modern Scientific Collaboration

Alfred Nobel’s 1895 will restricts the prize to a maximum of three individuals, a rule that faces scrutiny as massive global teams increasingly drive scientific discovery. Perlmann acknowledged that committee members discuss the restriction, conceding that limiting recognition may eventually present difficulties as scientific collaborations grow larger. Despite those collaborative structures, Perlmann defended the current focus on individual pioneers who dare to challenge established consensus within the scientific community, pointing out that individual drive remains central to major breakthroughs.